Updated just now · Live
Stock analysis, price data, and AI-powered insights for Inhibikase Therapeutics Inc (IKT).
Inhibikase Therapeutics Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for IKT.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). IKT Stock Intelligence Report. [stoxpulse.com/stocks/ikt]
Disclaimer: The information on this page about Inhibikase Therapeutics Inc (IKT) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Inhibikase Therapeutics Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
No recent signals.
StoxPulse AI results for IKT: Pulse Score 51/100. Primary sentiment trends from 0 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$239.0M
P/E Ratio
—
EPS
$-0.13
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—